Acurable to Launch Revolutionary Sleep Apnoea Testing Device in the US After Securing New FDA Clearance
London, 24th May, 2023
Following a successful launch in Europe, London-based medical device company Acurable is aiming to …
Acurable raises €11m in Series A funding round
London, 3rd October 2022
Acurable, an award-winning wearable medical devices company, today announced an €11m investment as a …
AcuPebble SA100 offers automated sleep apnoea diagnosis equivalent to cardiorespiratory polygraphy
London, 26th January 2022
AcuPebble SA100 is clinically equivalent to cardiorespiratory polygraphy for the automated diagnosis …